Acorah Software Products - Accounts Production 19.1.200 false true false true No description of principal activity 26 November 2024 30 November 2025 30 November 2025 SC830087 Dr Andrew Ross iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure SC830087 2024-11-25 SC830087 2025-11-30 SC830087 2024-11-26 2025-11-30 SC830087 frs-core:CurrentFinancialInstruments 2025-11-30 SC830087 frs-bus:PrivateLimitedCompanyLtd 2024-11-26 2025-11-30 SC830087 frs-bus:FilletedAccounts 2024-11-26 2025-11-30 SC830087 frs-bus:Micro-entities 2024-11-26 2025-11-30 SC830087 frs-bus:AuditExempt-NoAccountantsReport 2024-11-26 2025-11-30 SC830087 frs-bus:Director1 2024-11-26 2025-11-30
Registered number: SC830087
Pharmachem Consulting Ltd
Unaudited Financial Statements
For The Year Ended 30 November 2025
Accountants Scotland Ltd
Chartered & Certified Accountants
The Old City Club
6 Southesk Street
Brechin
DD9 6DY
Balance Sheet
Registered number: SC830087
2025
£
Current assets 10,340
Creditors: Amounts Falling Due Within One Year (7,149 )
NET CURRENT ASSETS 3,191
TOTAL ASSETS LESS CURRENT LIABILITIES 3,191
Accruals and deferred income (360 )
NET ASSETS 2,831
CAPITAL AND RESERVES 2,831

Notes

1. General Information
Pharmachem Consulting Ltd is a private company, limited by shares, incorporated in Scotland, registered number SC830087 . The registered office is 43 Sutherland Avenue, Glasgow, G41 4ET.
2. Average Number of Employees
Average number of employees, including directors, during the year was: NIL
-
For the year ending 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr Andrew Ross
Director
9th March 2026